$280,000 of ULTRAGENYX PHARMACEUTICAL INC. lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to drug development, access and reimbursement for rare and ultra rare diseases. Issues related to drug development, access and reimbursement for rare and ultra rare diseases. Issues related to drug development, access and reimbursement for rare and ultra rare diseases."
You can find more data on corporate lobbying on Quiver Quantitative.
RARE Congressional Stock Trading
Members of Congress have traded $RARE stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $RARE stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 09/29.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
RARE Insider Trading Activity
RARE insiders have traded $RARE stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $RARE stock by insiders over the last 6 months:
- HOWARD HORN (Chief Financial Officer) has made 0 purchases and 4 sales selling 18,730 shares for an estimated $499,877.
- SHEHNAAZ SULIMAN sold 5,740 shares for an estimated $144,188
- KARAH HERDMAN PARSCHAUER (EVP and Chief Legal Officer) has made 0 purchases and 2 sales selling 3,799 shares for an estimated $94,101.
- CORAZON (CORSEE) D. SANDERS sold 2,000 shares for an estimated $50,100
- THEODORE ALAN HUIZENGA (SVP, Chief Accounting Officer) has made 0 purchases and 2 sales selling 1,444 shares for an estimated $19,662.
- ERIC CROMBEZ (EVP and Chief Medical Officer) sold 344 shares for an estimated $8,586
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
RARE Hedge Fund Activity
We have seen 155 institutional investors add shares of RARE stock to their portfolio, and 145 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- RTW INVESTMENTS, LP added 4,148,100 shares (+113.7%) to their portfolio in Q2 2026, for an estimated $138,505,059
- BLACKROCK, INC. added 3,354,678 shares (+46.0%) to their portfolio in Q2 2026, for an estimated $112,012,698
- AQR CAPITAL MANAGEMENT LLC added 1,982,785 shares (+43.3%) to their portfolio in Q2 2026, for an estimated $66,205,191
- JACOBS LEVY EQUITY MANAGEMENT, INC added 1,508,648 shares (+105.4%) to their portfolio in Q2 2026, for an estimated $50,373,756
- SOFINNOVA INVESTMENTS, INC. removed 1,428,383 shares (-45.4%) from their portfolio in Q2 2026, for an estimated $47,693,708
- MPM BIOIMPACT LLC added 1,418,215 shares (+inf%) to their portfolio in Q2 2026, for an estimated $47,354,198
- TWO SIGMA INVESTMENTS, LP added 1,415,380 shares (+64.2%) to their portfolio in Q2 2026, for an estimated $47,259,538
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
RARE Price Targets
Multiple analysts have issued price targets for $RARE recently. We have seen 6 analysts offer price targets for $RARE in the last 6 months, with a median target of $43.0.
Here are some recent targets:
- Luca Issi from RBC Capital set a target price of $40.0 on 07/07/2026
- Kristen Kluska from Cantor Fitzgerald set a target price of $96.0 on 05/21/2026
- Laura Chico from Wedbush set a target price of $26.0 on 05/08/2026
- Debjit Chattopadhyay from Guggenheim set a target price of $43.0 on 05/08/2026
- Benjamin Burnett from Wells Fargo set a target price of $47.0 on 05/06/2026
- Eliana Merle from Barclays set a target price of $43.0 on 04/29/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
